Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Fate of erythrocyte Cd-metallothionein in mice

Journal Article · · Toxicol. Appl. Pharmacol.; (United States)

Degradation of metallothionein (MT), which appears in erythrocytes following cadmium (Cd) administration, was investigated in mice. Cd-MT underwent only slight decomposition by hemolysate in an in vitro experiment unlike an 800g supernatant fraction of the liver homogenate. In an in vivo study, (/sup 3/H)diisopropylfluorophosphate was given to mice which had received /sup 109/CdCl2 to investigate the relationship between the decay of /sup 109/Cd-MT in the erythrocyte and the life span of the erythrocyte. A similar reduction pattern of radioactivity of /sup 109/Cd and /sup 3/H was observed. Erythrocytes containing /sup 109/Cd-MT obtained from mice preadministered with /sup 109/CdCl/sub 2/ was transfused to normal mice. The /sup 109/Cd radioactivity of erythrocytes decreased in a manner similar to Cd in erythrocytes of /sup 109/CdCl/sub 2/-administered mice. Contrary to this decrease of erythrocyte Cd in the transfused mice, Cd concentration of the spleen increased markedly. Cd increased also in the liver. These results indicate that erythrocyte MT degrades along with the erythrocyte. The Cd from this MT is deposited in the spleen and liver where blood cells are catabolized.

Research Organization:
Kobe-Gakuin Univ., Japan
OSTI ID:
5674436
Journal Information:
Toxicol. Appl. Pharmacol.; (United States), Journal Name: Toxicol. Appl. Pharmacol.; (United States) Vol. 2; ISSN TXAPA
Country of Publication:
United States
Language:
English